Endocrinologist and Associate Professor
Trillium Health Partners & Unity Health Toronto
University of Toronto
Mississauga, Ontario, Canada
Dr. Cheng is an Endocrinologist at Trillium Health Partners and St Michaels’ Hospital and an Associate Professor at the University of Toronto. She was involved with the development of the Diabetes Canada clinical practice guidelines from 2003 to 2020 and was Chair for the 2013 version. She served as Chair of the Scientific Planning Committee for the 2023 and 2024 American Diabetes Association annual scientific meetings and sat on the planning committees for EASD 2025 and IDF 2025. In addition, she is a co-host of the podcast series “Diabetes Care On Air” for the journal, Diabetes Care. In recognition of her contribution to the diabetes community, she has received the Outstanding Physician-Clinician in Diabetes Award from the American Diabetes Association and the Charles H. Best Award and the Gerald S. Wong Service Award from Diabetes Canada. She is also the creator of The Med Ed Pledge – an initiative to increase Diversity & Inclusion in continuing medical education (www.theMedEdPledge.com)
Disclosure(s): Abbott Diabetes Care: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Amgen Canada: Speaker/Honoraria (Ongoing); Aspen: Consultant (Ongoing); Astellas: Speaker/Honoraria (Ongoing); Astra zeneca: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Bausch Health: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Bayer Canada Inc: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Biomea: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Boehringer Ingelheim: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Dexcom Canada: Speaker/Honoraria (Ongoing); Eisai Pharmaceuticals: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Eli Lilly Canada: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Gan & Lee: Advisory Board (Ongoing); GlaxoSmithKline (GSK): Speaker/Honoraria (Ongoing); HLS Therapeutics: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Insulet Canada: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Medtronic Diabetes Canada: Speaker/Honoraria (Ongoing); MSD: Advisory Board (Ongoing); Novo Nordisk Canada: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Pfizer Canada: Speaker/Honoraria (Ongoing); Sandoz: Consultant (Ongoing); Sanofi: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Vertex: Consultant (Ongoing)
CC04 - Sleep Matters in Diabetes: Clinical Insights and Case Review
Thursday, November 27, 2025
12:15 - 12:35 Toronto
AS01 - Evolution of GLP-1 and GIP/GLP1 Therapies: From Trial Evidence to Clinical Practice
Thursday, November 27, 2025
13:00 - 14:15 Toronto
Thursday, November 27, 2025
18:30 - 20:00 Toronto
RDRS2 - Thyroid Eye Disease: An Endo-Ophtho-Patient collaboration
Friday, November 28, 2025
13:00 - 14:15 Toronto
CC12 - From Theory to Practice: How to Implement Type 1 Diabetes Early Detection in Your Clinic
Saturday, November 29, 2025
12:10 - 12:30 Toronto